Cellceutix Alerts Shareholders to National Media on Anti-Cancer Abilities of p53
October 09, 2015 09:57 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - October 09, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Retains Ashcroft Law Firm, Seeks Withdrawal of Complaint
October 02, 2015 06:19 ET
|
Cellceutix
BOSTON, MA--(Marketwired - October 02, 2015) - Cellceutix Corporation (OTC: CTIX), issues the following statement in connection with the recent filing of a frivolous and baseless lawsuit in New...
Enrollment Approximately 50 Percent Complete in Cellceutix Phase 2 Clinical Trial of Prurisol for Chronic Plaque Psoriasis
September 30, 2015 09:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - September 30, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Announces Brilacidin Data to Be Presented by ICPD at the Joint 55th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC)
September 16, 2015 07:40 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - September 16, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Announces Filing of Its Annual Report on Form 10-K
September 14, 2015 09:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - September 14, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Plans for Phase 2 Clinical Trial in Ovarian Cancer
September 08, 2015 07:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - September 08, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix Requesting Meeting With FDA on Kevetrin for Pediatric Retinoblastoma
August 24, 2015 07:00 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - August 24, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting Its Goals, Approaching End of Trial
August 20, 2015 07:39 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - August 20, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix' Kevetrin and Thymoma -- a Rare Cancer
August 11, 2015 08:30 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - August 11, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Cellceutix: Thank You
August 10, 2015 08:31 ET
|
Cellceutix
BEVERLY, MA--(Marketwired - August 10, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...